Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Building A Context-Driven Architecture Into Pharma Commercial Stacks
Sahitya Sridhar, Co-Founder, SynthioLabs. For the past decade, pharma's commercial transformation has followed a familiar playbook: Digitize engagement, add more channels and layer analytics on top. Customer relationship management (CRM) systems…
India's Top Bank in $1 Billion Funding for Sun Pharma's US Deal
State Bank of India plans to join a group of global lenders in funding Sun Pharmaceutical Industries Ltd. 's $12 billion overseas acquisition, according to people familiar with the matter. SBI, the country's largest bank by assets, is set to commit…
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Company announcement – No. 22 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL)…
Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)
Company announcement No. 23 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 23, 2026) Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
The space race is coming for pharma: Why drug development is heading to lower Earth orbit
Industries from semiconductors to fiber-optic cables stand to benefit from space research and manufacturing, but experts told CNBC that medicine could see the most immediate disruption. A flurry of companies is capitalizing on space, which allows…
Pharma stocks are showing strength. Charts predict this name could break out next
Pharmaceutical stocks have recently separated themselves from the broader market, and the group has become an increasingly important source of leadership within healthcare. Eli Lilly is the bellwether in the space and has already broken out to…
Fonds de solidarité FTQ Invests in CELYSTRA Pharma
Investment is part of a $20 million financing round MONTRÉAL, June 9, 2026 /CNW/ - To support the launch of CELYSTRA Pharma, the Fonds de solidarité FTQ has joined the company's founders and other investors in a $20 million financing…
India ready to open pharma market to innovative global products: Goyal
India is willing to open its market to high-quality and innovative products from the global pharma sector in return for preferential access for the domestic drug exports, Commerce and Industry Minister Piyush Goyal said on Monday. He said that the…
TD Asset Management Inc Boosts Stake in BridgeBio Pharma, Inc. $BBIO
TD Asset Management Inc increased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 62.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 144,180 shares of the company's stock…
Capital World Investors Raises Stock Holdings in NewAmsterdam Pharma Company N.V. $NAMS
Capital World Investors raised its position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 1.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…
Prudential PLC Decreases Stock Position in Royalty Pharma PLC $RPRX
Prudential PLC trimmed its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 94.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,575 shares of the…
Erste Asset Management GmbH Trims Holdings in BridgeBio Pharma, Inc. $BBIO
Erste Asset Management GmbH lessened its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 21.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission…
India Inc Battles Rising Gulf War Costs
Companies are already diversifying sourcing, raising prices, and reworking operating models as the disruption drags on. Prolonged West Asia conflict is raising freight, insurance and input costs across multiple sectors of India Inc. Automobile and…
Prediction: The Trump Bull Market Will Soon End -- But These 2 Stocks Will Keep Winning Anyway
The S&P 500 has roared higher over the past three years -- and since President Donald Trump's inauguration in January of last year, the famous benchmark has advanced more than 23%. Investors have rushed to buy high-growth players, particularly in…
GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B
LONDON — GSK said Tuesday it would buy the cancer-focused biotech Nuvalent in a deal worth $10.6 billion, as the British firm continues its expansion in oncology. The deal is the latest in a run of biopharma acquisitions in recent months, as…
Receive a Daily briefing on Pharma Industry News
Get Started